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affected adults
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Objectives: To examine the effects of a high interval training (IT) on power (P)
and oxygen uptake (VO2) at peak performance (peak) and ventilatory threshold
(VT) in severely affected CF patients unable to participate in a standard exercise
program (SEP), and to compare corresponding IT effects with those of SEP.
Methods: 43 CF patients (FEV140% pred.) underwent cardio-pulmonary exercise
testing. 20 patients (FEV1 25.5±7.5%; pred; SpO2< 90% at rest or P lower than
0.3W/kg) unable to participate in SEP were allocated to 5x20min per week IT
under supplemental oxygen via nasal cannula. The remaining 23 patients (FEV1
31.6±4.2%; p< 0.05) did 5x45min per week SEP.
Results: Lung function remained unchanged in both groups and main effects
(p< 0.05) of increases in body (2.5±3.3%) and fat free mass (5.5±3.1), and
PVAT (21.3±15.3%), VO2VAT (18.5±9.2%), and Ppeak (18.6±13.5) and VO2peak
(16.7±8.0%) were found. Partial effects were conﬁrmed (p< 0.05) in VO2VAT
(21.8±13.5%) after IT and Ppeak (23.9±18.3%) after SEP.
Conclusion: IT imposed as safe and effective in CF patients who are unable to
participate in SEP. Compared to SEP, IT improved submaximal exercise capacity
to a greater extent than SEP whereas responsiveness of maximal exercise capacity
was higher in the SEP. This seems to indicate a speciﬁc potential of IT for positive
peripheral muscular adaptations in spite of diminishing potential of pulmonary
improvement. IT may offer an alternative, effective and safe training regime with a
greater potential of training effects helping to cope better with the physical demands
of daily activities than SEP.
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Objectives: Theoretical beneﬁts of delivering intravenous (IV) antibiotics at home
compared to in hospital include improved quality of life (QoL) and maintaining
physical activity. Regular exercise and habitual physical activity are generally
considered beneﬁcial for people with CF in improving QoL and slowing lung
function decline, but physical activity in patients receiving IV antibiotics for
pulmonary exacerbations is not well researched. The purpose of this prospective
observational cohort study was to directly compare physical activity, QoL and
nutritional outcomes in patients receiving IV antibiotics in hospital and at home.
Methods: 45 CF adults chronically infected with P. aeruginosa requiring IV
antibiotics for pulmonary exacerbations were recruited. Location of treatment (home
or hospital) was based on clinical criteria, ability to deliver home IV antibiotics and
patient preference. During the ﬁrst and last 3 days of IV antibiotics, subjects were
asked to wear ActiGraph® activity monitors and complete food diaries. Subjects
were also asked to complete the modiﬁed shuttle test, CFQ-R and habitual activity
estimation scale (HAES) questionnaires at the start and end of therapy.
Conclusion: Activity monitor and HAES data demonstrated no signiﬁcant differ-
ence between the physical activity of subjects receiving IV antibiotics in hospital
and at home, with both groups spending the majority of time being sedentary.
Subjects at home reported a signiﬁcantly greater increase in the CFQ-R respiratory
domain over the course of antibiotics, but no other differences in clinical outcomes
were found.
